Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review ; day:7 ; month:1 ; year:2019 ; pages:1-9
Drugs - real world outcomes ; (7.1.2019), 1-9
- Creator
-
Joshi, Reeti
Latremouille-Viau, Dominick
Meiselbach, Mark K.
Xie, Jipan
Park, Yujin
Sunkureddi, Prashanth
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-018-0146-9
- URN
-
urn:nbn:de:101:1-2019021102252044142149
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Joshi, Reeti
- Latremouille-Viau, Dominick
- Meiselbach, Mark K.
- Xie, Jipan
- Park, Yujin
- Sunkureddi, Prashanth
- SpringerLink (Online service)
Other Objects (12)
Secukinumab: A Review in Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
Andersson lesion in ankylosing spondylitis
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis : results from phase IV ASTRUM study
Surgical treatment of ankylosing spondylitis deformity
Ankylosierende Spondylitis: Secukinumab lindert Fatigue schnell und anhaltend
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Secukinumab: A Review in Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
Andersson lesion in ankylosing spondylitis
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis : results from phase IV ASTRUM study
Surgical treatment of ankylosing spondylitis deformity
Ankylosierende Spondylitis: Secukinumab lindert Fatigue schnell und anhaltend
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Secukinumab: A Review in Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
Andersson lesion in ankylosing spondylitis
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis : results from phase IV ASTRUM study
Surgical treatment of ankylosing spondylitis deformity
Ankylosierende Spondylitis: Secukinumab lindert Fatigue schnell und anhaltend
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?